Latest: FDA Approves New Biosimilar for Oncology Treatment
Pharmaceutical

Friends of Cancer Research and MMS partner to improve interpretation of cancer trial survival data

by PharmaTimes
0 Comments
0 Mins
Friends of Cancer Research has announced a new collaboration with global clinical research organisation, MMS, to develop decision frameworks that will help interpret interim overall survival (OS) data in oncology trials.
Tags:
PharmaTimes
Author

PharmaTimes

Previous Post
FDA approves Ionis’ hereditary angioedema drug
Next Post
ANGLE partners with Myriad Genetics to explore blood-based cancer testing
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago